Invention Application
US20120309787A1 INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS AND USES THEREOF
失效
胰岛素调节氨基酸抑制剂（IRAP）抑制剂及其用途
- Patent Title: INSULIN-REGULATED AMINOPEPTIDASE (IRAP) INHIBITORS AND USES THEREOF
- Patent Title (中): 胰岛素调节氨基酸抑制剂（IRAP）抑制剂及其用途
-
Application No.: US13570938Application Date: 2012-08-09
-
Publication No.: US20120309787A1Publication Date: 2012-12-06
- Inventor: SIEW YEEN CHAI , Michael William Parker , Anthony Lloyd Albiston , Frederick A.O. Mendelsohn , Keith Geoffrey Watson
- Applicant: SIEW YEEN CHAI , Michael William Parker , Anthony Lloyd Albiston , Frederick A.O. Mendelsohn , Keith Geoffrey Watson
- Applicant Address: AU Fitzroy AU Parkville
- Assignee: St. Vincent's Institute of Medical Research,Howard Florey Institute
- Current Assignee: St. Vincent's Institute of Medical Research,Howard Florey Institute
- Current Assignee Address: AU Fitzroy AU Parkville
- Main IPC: A61K31/4709
- IPC: A61K31/4709 ; A61P25/00
Abstract:
The present invention relates to inhibitors of insulin-regulated aminopeptidase (IRAP) and methods for inhibiting same, as well as compositions comprising said inhibitors. In particular, the inhibitors of the present invention may be useful in therapeutic applications including enhancing memory and learning functions.
Public/Granted literature
- US08377963B2 Insulin-regulated aminopeptidase (IRAP) inhibitors and uses thereof Public/Granted day:2013-02-19
Information query
IPC分类:
